YMTX Annual CFO
-$48.91 M
-$30.98 M-172.69%
31 December 2021
Summary:
As of January 23, 2025, YMTX annual cash flow from operations is -$48.91 million, with the most recent change of -$30.98 million (-172.69%) on December 31, 2021. During the last 3 years, it has fallen by -$21.71 million (-79.78%).YMTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMTX Quarterly CFO
-$3.68 M
+$1.61 M+30.42%
30 September 2022
Summary:
As of January 23, 2025, YMTX quarterly cash flow from operations is -$3.68 million, with the most recent change of +$1.61 million (+30.42%) on September 30, 2022. Over the past year, it has increased by +$4.59 million (+55.53%).YMTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMTX TTM CFO
-$25.54 M
+$4.59 M+15.25%
30 September 2022
Summary:
As of January 23, 2025, YMTX TTM cash flow from operations is -$25.54 million, with the most recent change of +$4.59 million (+15.25%) on September 30, 2022. Over the past year, it has increased by +$26.20 million (+50.65%).YMTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
YMTX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -172.7% | +55.5% | +50.6% |
| 3 y3 years | -79.8% | +55.6% | -208.3% |
| 5 y5 years | -79.8% | +55.6% | -208.3% |
YMTX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +172.7% | -146.4% | +300.4% |
Yumanity Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2022 | - | -$3.68 M(-30.4%) | -$25.54 M(-15.3%) |
| June 2022 | - | -$5.29 M(-32.4%) | -$30.13 M(-12.6%) |
| Mar 2022 | - | -$7.83 M(-10.4%) | -$34.46 M(-29.6%) |
| Dec 2021 | -$48.91 M | -$8.74 M(+5.6%) | -$48.91 M(-5.5%) |
| Sept 2021 | - | -$8.28 M(-13.9%) | -$51.74 M(+45.6%) |
| June 2021 | - | -$9.62 M(-56.9%) | -$35.54 M(+11.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$22.29 M(+92.8%) | -$31.94 M(+78.1%) |
| Dec 2020 | -$17.94 M(-34.1%) | -$11.56 M(-245.8%) | -$17.94 M(+181.3%) |
| Sept 2020 | - | $7.93 M(-231.7%) | -$6.38 M(-55.4%) |
| June 2020 | - | -$6.02 M(-27.3%) | -$14.30 M(+72.7%) |
| Mar 2020 | - | -$8.28 M | -$8.28 M |
| Dec 2019 | -$27.21 M | - | - |
FAQ
- What is Yumanity Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Yumanity Therapeutics?
- What is Yumanity Therapeutics annual CFO year-on-year change?
- What is Yumanity Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Yumanity Therapeutics?
- What is Yumanity Therapeutics quarterly CFO year-on-year change?
- What is Yumanity Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Yumanity Therapeutics?
- What is Yumanity Therapeutics TTM CFO year-on-year change?
What is Yumanity Therapeutics annual cash flow from operations?
The current annual CFO of YMTX is -$48.91 M
What is the all time high annual CFO for Yumanity Therapeutics?
Yumanity Therapeutics all-time high annual cash flow from operations is -$17.94 M
What is Yumanity Therapeutics annual CFO year-on-year change?
Over the past year, YMTX annual cash flow from operations has changed by -$30.98 M (-172.69%)
What is Yumanity Therapeutics quarterly cash flow from operations?
The current quarterly CFO of YMTX is -$3.68 M
What is the all time high quarterly CFO for Yumanity Therapeutics?
Yumanity Therapeutics all-time high quarterly cash flow from operations is $7.93 M
What is Yumanity Therapeutics quarterly CFO year-on-year change?
Over the past year, YMTX quarterly cash flow from operations has changed by +$4.59 M (+55.53%)
What is Yumanity Therapeutics TTM cash flow from operations?
The current TTM CFO of YMTX is -$25.54 M
What is the all time high TTM CFO for Yumanity Therapeutics?
Yumanity Therapeutics all-time high TTM cash flow from operations is -$6.38 M
What is Yumanity Therapeutics TTM CFO year-on-year change?
Over the past year, YMTX TTM cash flow from operations has changed by +$26.20 M (+50.65%)